| Name | Title | Contact Details |
|---|
Twin Health invented the Whole Body Digital Twin™ to help reverse and prevent chronic metabolic diseases, improve energy and physical health, and extend lifespan. We combine advanced technology and medical science to heal the most complex and dynamic system of all—the human metabolism. Twin is headquartered in California, USA and Chennai, India. Twin Health does not interview prospective employees via any apps, nor will we ask you to purchase equipment or provide financial information prior to joining.
Groups360™️ was founded in 2014 with the goal of simplifying and transforming the ways meetings are booked. The company`s search engine, GroupSync™️, using its proprietary matching algorithms designed specifically for meeting planners, has helped place thousands of events at the right venue, saving planners time and money. GroupSync`s price predictor tool delivers improved transparency, reducing time and effort required to book meetings for both the hotel and the planner. Groups360`s management team has decades of experience in the meetings and events industry and provides the right mix of technology and experienced advisors. Using GroupSync, planners can search more than 200,000 properties in 225 countries and territories.
Teva Neuroscience is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Kansas City, MO. To find more information about Teva Neuroscience, please visit www.tevaneuro.com
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Veran Medical Technologies, Inc., an image guided medical device company, develops a suite of products to enable physicians to diagnose disease and deliver therapies. It offers standards for minimally invasive delivery of interventional oncology therapies. The company provides plug-n-play delivery systems and navigated instruments. Its IG4 Platform allows clinicians to visualize various types of information integrated with a CT dataset, such as respiration, contrast enhanced structures, PET, and ultrasound. The company also provides SPiN Drive System that acts as a GPS-like system to enable pulmonologists and surgeons to access peripheral solitary pulmonary nodules to diagnose malignancy. Veran Medical Technologies, Inc. was incorporated in 2007 and is headquartered in St. Louis, Missouri.